The Enterprise Value as of December 2024 (TTM) for 2seventy bio, Inc. (TSVT) is 343.77M

According to 2seventy bio, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 343.77M. This represents a change of -18.34% compared to the average of 420.98M of the last 4 quarters.

2seventy bio, Inc. (TSVT) Historical Enterprise Value (quarterly & annually)

How has TSVT Enterprise Value performed in the past?

The mean historical Enterprise Value of 2seventy bio, Inc. over the last ten years is 474.19M. The current 343.77M Enterprise Value has changed 7.15% with respect to the historical average. Over the past ten years (40 quarters), TSVT's Enterprise Value was at its highest in in the December 2021 quarter at 756.29M. The Enterprise Value was at its lowest in in the June 2020 quarter at 0.

2seventy bio, Inc. (TSVT) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of 2seventy bio, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

2seventy bio, Inc. (TSVT) Average Enterprise Value

How has TSVT Enterprise Value performed in the past?

The current Enterprise Value of 2seventy bio, Inc. (TSVT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

2seventy bio, Inc. (TSVT) Enterprise Value vs. Peers

How is TSVT’s Enterprise Value compared to its peers?

2seventy bio, Inc.’s Enterprise Value is less than Intercept Pharmaceuticals, Inc. (915.81M), greater than Puma Biotechnology, Inc. (167.35M), less than Iovance Biotherapeutics, Inc. (2.20B), less than Sarepta Therapeutics, Inc. (12.84B), less than Day One Biopharmaceuticals, Inc. (857.57M), greater than Inozyme Pharma, Inc. (210.44M), greater than Zentalis Pharmaceuticals, Inc. (228.61M), less than Syndax Pharmaceuticals, Inc. (983.46M), less than Protagonist Therapeutics, Inc. (2.22B), greater than Theseus Pharmaceuticals, Inc. (138.26M), less than Cullinan Oncology, Inc. (614.81M), greater than Mersana Therapeutics, Inc. (152.76M), less than Relay Therapeutics, Inc. (605.49M), less than Arcus Biosciences, Inc. (1.31B), less than Stoke Therapeutics, Inc. (451.87M), greater than Kezar Life Sciences, Inc. (29.92M), less than Phathom Pharmaceuticals, Inc. (354.56M), less than Replimune Group, Inc. (904.39M), less than Chinook Therapeutics, Inc. (2.63B), less than DICE Therapeutics, Inc. (1.82B), less than Pliant Therapeutics, Inc. (801.51M), less than Crinetics Pharmaceuticals, Inc. (4.74B), less than Ascendis Pharma A/S (8.14B),

Build a custom stock screener for 2seventy bio, Inc. (TSVT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like 2seventy bio, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

2seventy bio, Inc. (TSVT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like 2seventy bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.